CRGX (Cargo Therapeutics) Other Long-Term Liabilities : $0.00 Mil (As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Cargo Therapeutics Other Long-Term Liabilities?

Cargo Therapeutics's other long-term liabilities for the quarter that ended in Sep. 2024 was $0.00 Mil.

Cargo Therapeutics's quarterly other long-term liabilities stayed the same from Mar. 2024 ($-0.00 Mil) to Jun. 2024 ($-0.00 Mil) but then increased from Jun. 2024 ($-0.00 Mil) to Sep. 2024 ($0.00 Mil).

Cargo Therapeutics's annual other long-term liabilities increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.25 Mil) but then declined from Dec. 2022 ($0.25 Mil) to Dec. 2023 ($0.22 Mil).

Cargo Therapeutics Other Long-Term Liabilities Historical Data

The historical data trend for Cargo Therapeutics's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cargo Therapeutics Other Long-Term Liabilities Chart

Cargo Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Cargo Therapeutics Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Long-Term Liabilities	Get a 7-Day Free Trial						-	-	-	-	-

Cargo Therapeutics Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Cargo Therapeutics Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Cargo Therapeutics's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Cargo Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cargo Therapeutics Inc (NAS:CRGX) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

1900 Alameda De Las Pulgas, Suite 350, San Mateo, CA, USA, 94403

Website

https://www.cargo-tx.com

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.